A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK. (Q46495014)
Jump to navigation
Jump to search
scientific article published in April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK. |
scientific article published in April 2005 |
Statements
1 reference
A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK. (English)
1 reference
Alan G Wade
1 reference
Idris Toumi
1 reference
Michiel E H Hemels
1 reference
1 April 2005
1 reference
21
1 reference
4
1 reference
631-642
1 reference